Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies

Hepatocellular carcinoma (HCC) is a global problem constituting the second leading cause of cancer deaths worldwide, thereby necessitating an accurate and cost-effective solution for managing care. Ultrasound is well poised to address this need due to its low cost, portability, safety, and excellent...

Full description

Saved in:

Bibliographic Details
Published in	Abdominal imaging Vol. 46; no. 8; pp. 3579 - 3595
Main Authors	Eisenbrey, John R., Gabriel, Helena, Savsani, Esika, Lyshchik, Andrej
Format	Journal Article
Language	English
Published	New York Springer US 01.08.2021 Springer Nature B.V
Subjects	Cancer Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - therapy Computed tomography Contrast Media Gastroenterology Hepatocellular carcinoma Hepatology Humans Imaging Liver Liver cancer Liver Neoplasms - diagnostic imaging Liver Neoplasms - therapy Magnetic Resonance Imaging Medical diagnosis Medicine Medicine & Public Health Neoplasm Recurrence, Local Radiology Special Section: HCC Treatment Temporal resolution Tumors Ultrasonic imaging Ultrasonography Ultrasound HCC Transarterial embolization Contrast-enhanced ultrasound LI-RADS Ultrasound Ablation
Online Access	Get full text
ISSN	2366-004X 2366-0058 2366-0058
DOI	10.1007/s00261-021-03059-y

Cover

Loading…

Abstract	Hepatocellular carcinoma (HCC) is a global problem constituting the second leading cause of cancer deaths worldwide, thereby necessitating an accurate and cost-effective solution for managing care. Ultrasound is well poised to address this need due to its low cost, portability, safety, and excellent temporal resolution. The role of ultrasound for HCC screening has been well established and supported by multiple international guidelines. Similarly, contrast-enhanced ultrasound (CEUS) can be used for the characterization of focal liver lesions in high-risk populations, and standardized criteria for CEUS have been established by the American College of Radiology Liver Imaging Reporting & Data System (LI-RADS). Following HCC identification, CEUS can also be highly beneficial in treatment planning, delivery, and monitoring HCC response to locoregional therapies. Specific advantages of CEUS include providing real-time treatment guidance and improved diagnostic performance for the detection of residual tumor viability or recurrence, thereby identifying patients in need of retreatment substantially earlier than contrast-enhanced CT and MRI. This review provides a primer on ultrasound and CEUS for the screening and characterization of HCC, with an emphasis on assessing tumor response to locoregional therapies.
AbstractList	Hepatocellular carcinoma (HCC) is a global problem constituting the second leading cause of cancer deaths worldwide, thereby necessitating an accurate and cost-effective solution for managing care. Ultrasound is well poised to address this need due to its low cost, portability, safety, and excellent temporal resolution. The role of ultrasound for HCC screening has been well established and supported by multiple international guidelines. Similarly, contrast-enhanced ultrasound (CEUS) can be used for the characterization of focal liver lesions in high-risk populations, and standardized criteria for CEUS have been established by the American College of Radiology Liver Imaging Reporting & Data System (LI-RADS). Following HCC identification, CEUS can also be highly beneficial in treatment planning, delivery, and monitoring HCC response to locoregional therapies. Specific advantages of CEUS include providing real-time treatment guidance and improved diagnostic performance for the detection of residual tumor viability or recurrence, thereby identifying patients in need of retreatment substantially earlier than contrast-enhanced CT and MRI. This review provides a primer on ultrasound and CEUS for the screening and characterization of HCC, with an emphasis on assessing tumor response to locoregional therapies.Hepatocellular carcinoma (HCC) is a global problem constituting the second leading cause of cancer deaths worldwide, thereby necessitating an accurate and cost-effective solution for managing care. Ultrasound is well poised to address this need due to its low cost, portability, safety, and excellent temporal resolution. The role of ultrasound for HCC screening has been well established and supported by multiple international guidelines. Similarly, contrast-enhanced ultrasound (CEUS) can be used for the characterization of focal liver lesions in high-risk populations, and standardized criteria for CEUS have been established by the American College of Radiology Liver Imaging Reporting & Data System (LI-RADS). Following HCC identification, CEUS can also be highly beneficial in treatment planning, delivery, and monitoring HCC response to locoregional therapies. Specific advantages of CEUS include providing real-time treatment guidance and improved diagnostic performance for the detection of residual tumor viability or recurrence, thereby identifying patients in need of retreatment substantially earlier than contrast-enhanced CT and MRI. This review provides a primer on ultrasound and CEUS for the screening and characterization of HCC, with an emphasis on assessing tumor response to locoregional therapies. Hepatocellular carcinoma (HCC) is a global problem constituting the second leading cause of cancer deaths worldwide, thereby necessitating an accurate and cost-effective solution for managing care. Ultrasound is well poised to address this need due to its low cost, portability, safety, and excellent temporal resolution. The role of ultrasound for HCC screening has been well established and supported by multiple international guidelines. Similarly, contrast-enhanced ultrasound (CEUS) can be used for the characterization of focal liver lesions in high-risk populations, and standardized criteria for CEUS have been established by the American College of Radiology Liver Imaging Reporting & Data System (LI-RADS). Following HCC identification, CEUS can also be highly beneficial in treatment planning, delivery, and monitoring HCC response to locoregional therapies. Specific advantages of CEUS include providing real-time treatment guidance and improved diagnostic performance for the detection of residual tumor viability or recurrence, thereby identifying patients in need of retreatment substantially earlier than contrast-enhanced CT and MRI. This review provides a primer on ultrasound and CEUS for the screening and characterization of HCC, with an emphasis on assessing tumor response to locoregional therapies.
Author	Eisenbrey, John R. Gabriel, Helena Lyshchik, Andrej Savsani, Esika
AuthorAffiliation	1 Department of Radiology, Thomas Jefferson University, 132 South 10th St, 796E Main Building, Philadelphia, PA 19107, USA 2 Department of Radiology, Northwestern University, Chicago, IL, USA
AuthorAffiliation_xml	– name: 2 Department of Radiology, Northwestern University, Chicago, IL, USA – name: 1 Department of Radiology, Thomas Jefferson University, 132 South 10th St, 796E Main Building, Philadelphia, PA 19107, USA
Author_xml	– sequence: 1 givenname: John R. orcidid: 0000-0001-6411-3424 surname: Eisenbrey fullname: Eisenbrey, John R. email: John.Eisenbrey@jefferson.edu organization: Department of Radiology, Thomas Jefferson University – sequence: 2 givenname: Helena surname: Gabriel fullname: Gabriel, Helena organization: Department of Radiology, Northwestern University – sequence: 3 givenname: Esika surname: Savsani fullname: Savsani, Esika organization: Department of Radiology, Thomas Jefferson University – sequence: 4 givenname: Andrej surname: Lyshchik fullname: Lyshchik, Andrej organization: Department of Radiology, Thomas Jefferson University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33825927$$D View this record in MEDLINE/PubMed
BookMark	eNp9UU1v1DAQtVAR_aB_gAOyxKUcAmM7dpILUhWVFqkSB6jEzXKSya6rrL3YDtL-e5xuWaCHHiyPZt5780bvlBw575CQNww-MIDqYwTgihXA8xMgm2L3gpxwoVQBIOujQ13-OCbnMd4DAFOSMS5fkWMhai4bXp0Q33qXgompQLc2rseBztPS8LMb6EV7dfftPbWO3rQtHaxZOR9tpCbPTIwY4wZdon6kad74QAPGrXcRafJ08r0PuLLemYmmNQaztRhfk5ejmSKeP_5n5O7z1ff2prj9ev2lvbwt-rIqUyE6XjEzSskRRIl8gKHjXQd8rNggUdUDb3JdCsE603T1aEYmVV9XY6cQFBNn5NNedzt3Gxx6XK6c9DbYjQk77Y3V_0-cXeuV_6VrqRoFZRa4eBQI_ueMMemNjT1Ok3Ho56i5hEYxqGHZ9e4J9N7PIZ-9oCSvZCMqlVFv_3V0sPIniwzge0AffIwBxwOEgV4y1_vMdc5cP2Sud5lUPyH1NplkH1K10_NUsafGvMetMPy1_QzrN5KpwjQ
CitedBy_id	crossref_primary_10_3389_fonc_2023_1123493 crossref_primary_10_3390_app13084797 crossref_primary_10_3390_diagnostics13040625 crossref_primary_10_1007_s00261_023_03806_3 crossref_primary_10_37015_AUDT_2023_230041 crossref_primary_10_2147_JHC_S353914 crossref_primary_10_1007_s00330_024_11314_1 crossref_primary_10_1055_s_0041_1741520 crossref_primary_10_1007_s00261_024_04625_w crossref_primary_10_1007_s00261_023_04033_6 crossref_primary_10_3390_cancers16101916 crossref_primary_10_3233_CH_211355 crossref_primary_10_4240_wjgs_v16_i11_3400 crossref_primary_10_1016_j_ultrasmedbio_2024_10_011 crossref_primary_10_7759_cureus_36082 crossref_primary_10_3390_jcm13247720 crossref_primary_10_2214_AJR_23_30156 crossref_primary_10_1016_j_ultrasmedbio_2024_05_015 crossref_primary_10_1155_2022_2940654 crossref_primary_10_11569_wcjd_v29_i18_1084 crossref_primary_10_3390_cancers16030551 crossref_primary_10_3390_diagnostics12020374 crossref_primary_10_1053_j_sult_2023_03_002 crossref_primary_10_37015_AUDT_2021_210018 crossref_primary_10_4254_wjh_v14_i5_911 crossref_primary_10_1016_j_crad_2023_09_015 crossref_primary_10_3389_fmed_2024_1388728 crossref_primary_10_1016_j_yasu_2023_03_003 crossref_primary_10_1148_radiol_230727 crossref_primary_10_1007_s00261_021_03248_9 crossref_primary_10_1016_j_wfumbo_2023_100020 crossref_primary_10_3390_diagnostics12102272 crossref_primary_10_1097_TA_0000000000004397 crossref_primary_10_3390_cancers15225396 crossref_primary_10_1007_s00330_024_10915_0 crossref_primary_10_3390_cancers15153854 crossref_primary_10_3390_metabo14090513 crossref_primary_10_1002_jum_16608 crossref_primary_10_1097_MD_0000000000040108 crossref_primary_10_1148_radiol_232369 crossref_primary_10_3390_diagnostics13122025 crossref_primary_10_1055_a_2160_3035
Cites_doi	10.2214/ajr.183.1.1830153 10.1016/j.jhep.2006.10.020 10.1097/RUQ.0000000000000513 10.1053/j.gastro.2004.09.031 10.1148/rg.2017160123 10.1016/j.diii.2016.09.002 10.1007/s00261-018-1802-y 10.1080/02656736.2017.1373306 10.1016/j.ultrasmedbio.2007.05.004 10.1002/hep.27915 10.1016/j.ultrasmedbio.2020.05.010 10.2214/ajr.177.2.1770375 10.4254/wjh.v7.i14.1866 10.2214/ajr.181.1.1810057 10.1007/BF01438313 10.1007/s00261-011-9794-x 10.1159/000173430 10.1007/s00261-011-9828-4 10.1016/j.ejrad.2005.03.023 10.1007/s00330-015-3611-9 10.1007/s00261-009-9551-6 10.1016/j.ctrv.2011.11.004 10.7863/jum.2006.25.4.477 10.1007/s00432-004-0552-0 10.1016/j.crad.2014.12.003 10.3892/etm.2016.3448 10.1016/j.jceh.2014.03.048 10.1245/s10434-014-4165-9 10.2214/ajr.181.1.1810065 10.1002/hep.24199 10.1016/j.crad.2017.07.021 10.1016/j.ultrasmedbio.2015.05.004 10.1007/s11901-020-00546-6 10.1007/s40477-019-00366-5 10.7863/ultra.34.5.859 10.1002/jum.15118 10.1002/hep.20465 10.1088/2057-1976/aabb14 10.4329/wjr.v4.i8.379 10.1016/S0140-6736(18)30010-2 10.1055/s-0031-1281676 10.1053/jhep.2002.32089 10.1016/j.jus.2012.09.001 10.1007/s00270-018-2082-1 10.1007/BF02602962 10.1148/radiol.2019191086 10.1016/j.jvir.2011.11.029 10.1053/j.gastro.2010.10.049 10.1148/radiol.2321030821 10.1016/j.ultrasmedbio.2013.03.030 10.1016/j.jacr.2017.08.045 10.4254/wjh.v10.i1.95 10.3233/CH-168113 10.1007/s00261-008-9446-y 10.1016/j.ultrasmedbio.2014.02.017 10.3233/CH-2012-1598 10.1002/lt.20036 10.1007/s13244-014-0315-7 10.1007/s00330-019-06553-6 10.1148/radiol.2018171768 10.2214/AJR.04.1916 10.1007/s00261-016-1016-0 10.18632/oncotarget.20049 10.7863/jum.2003.22.11.1163 10.1016/j.ejrad.2018.05.030 10.2214/ajr.180.3.1800703 10.1016/j.semradonc.2011.05.004 10.3748/wjg.v8.i4.658 10.1148/radiol.2020202321 10.1109/ULTSYM.2019.8926264 10.1016/j.jvir.2006.10.016 10.1007/s00270-020-02712-1 10.1102/1470-7330.2011.9042
ContentType	Journal Article
Copyright	The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.
Copyright_xml	– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 – notice: 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ JQ2 K7- K9. KB0 LK8 M0S M1P M7P M7Z NAPCQ P5Z P62 P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1007/s00261-021-03059-y
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Local Electronic Collection Information Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Computer Science Collection Computer Science Database (ProQuest) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database (ProQuest) Biochemistry Abstracts 1 Nursing & Allied Health Premium Advanced Technologies & Aerospace Database (ProQuest) ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Computer Science Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Computer Science Collection SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Biochemistry Abstracts 1 ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE Computer Science Database
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2366-0058
EndPage	3595
ExternalDocumentID	PMC8569604 33825927 10_1007_s00261_021_03059_y
Genre	Journal Article Review Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: National Cancer Institute grantid: R01 CA215520; R01 CA238241; R01 CA194307 funderid: http://dx.doi.org/10.13039/100000054 – fundername: NCI NIH HHS grantid: R01 CA215520 – fundername: NCI NIH HHS grantid: R01 CA194307 – fundername: NCI NIH HHS grantid: R01 CA238241
GroupedDBID	-EM 04C 0R~ 29~ 2J2 2JN 2JY 2KG 2KM 2LR 406 53G 5VS 7RV 7X7 88E 8AO 8FH 8FI 8FJ 95- AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAYIU AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHVE ACIWK ACKNC ACMDZ ACMLO ACOKC ACPIV ACPRK ACUDM ACZOJ ADBBV ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEKMD AEMSY AEOHA AESKC AEVLU AEXYK AFBBN AFEXP AFJLC AFKRA AFLOW AFQWF AFRAH AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWZB AGYKE AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AILAN AITGF AJBLW AJOOF AJRNO AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AOCGG ARAPS ARMRJ AXYYD AZFZN B-. BBNVY BDATZ BENPR BGLVJ BGNMA BHPHI BMSDO BSONS CCPQU CSCUP DDRTE DNIVK DPUIP EBLON EBS EIHBH EIOEI EJD EMB EMOBN FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA GGCAI GNWQR GRRUI H13 HCIFZ HMCUK IKXTQ IMOTQ ITM IWAJR J-C JZLTJ K7- KOV LK8 LLZTM M1P M4Y M7P NAPCQ NPVJJ NQJWS NU0 O9J PQQKQ PROAC PSQYO PT4 QOR R89 ROL RSV S16 SCLPG SDE SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN TSG UG4 UKHRP UOJIU UTJUX UZXMN VFIZW W23 YLTOR Z7X Z83 Z87 Z8V Z8W Z91 ZMTXR AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM --- .86 .VR 06C 06D 0VY 1N0 23M 2~H 30V 36B 3V. 4.4 408 409 40D 40E 5GY 5RE 67Z 6NX 7XB 8FD 8FE 8FG 8FK 8TC 95. 95~ 96X AAWCG AAWTL AAYQN ABBXA ABOCM ACOMO ADHIR ADIMF AEGAL AENEX AEPYU AETLH AFWTZ AHAVH AIIXL AKMHD ALWAN AZQEC BA0 BKEYQ BPHCQ BVXVI CS3 DL5 DWQXO ESBYG EX3 F5P FEDTE FR3 G-Y G-Z GGRSB GJIRD GNUQQ GQ7 GQ8 GXS HF~ HG5 HMJXF HQYDN HRMNR HVGLF I09 IHE IJ- IXC IZIGR IZQ I~Z J0Z JQ2 K6V K9. KDC KPH LAS M7Z MA- N9A NB0 O93 O9I OAM OVD P19 P62 P64 P9S PF0 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q2X QOK QOS R9I RHV RPX RRX S27 S37 S3B SAP SDH SHX SMD T13 TSV TT1 TUC U2A U9L VC2 WH7 WJK WK8 WOW Z45 ZOVNA 7X8 5PM ABRTQ
ID	FETCH-LOGICAL-c474t-3b271af552e034e2d0db2bb02f71d5e68d292f74331ba9b8faf156c87fb6e0613
IEDL.DBID	AGYKE
ISSN	2366-004X 2366-0058
IngestDate	Thu Aug 21 18:30:36 EDT 2025 Fri Jul 11 00:05:26 EDT 2025 Fri Jul 25 09:30:03 EDT 2025 Wed Feb 19 02:23:20 EST 2025 Tue Jul 01 02:12:37 EDT 2025 Thu Apr 24 23:08:44 EDT 2025 Fri Feb 21 02:48:18 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	8
Keywords	HCC Transarterial embolization Contrast-enhanced ultrasound LI-RADS Ultrasound Ablation
Language	English
License	2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c474t-3b271af552e034e2d0db2bb02f71d5e68d292f74331ba9b8faf156c87fb6e0613
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
ORCID	0000-0001-6411-3424
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/8569604
PMID	33825927
PQID	2552759376
PQPubID	31175
PageCount	17
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_8569604 proquest_miscellaneous_2509610801 proquest_journals_2552759376 pubmed_primary_33825927 crossref_primary_10_1007_s00261_021_03059_y crossref_citationtrail_10_1007_s00261_021_03059_y springer_journals_10_1007_s00261_021_03059_y
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2021-08-01
PublicationDateYYYYMMDD	2021-08-01
PublicationDate_xml	– month: 08 year: 2021 text: 2021-08-01 day: 01
PublicationDecade	2020
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States
PublicationTitle	Abdominal imaging
PublicationTitleAbbrev	Abdom Radiol
PublicationTitleAlternate	Abdom Radiol (NY)
PublicationYear	2021
Publisher	Springer US Springer Nature B.V
Publisher_xml	– name: Springer US – name: Springer Nature B.V
References	Moschouris, Malagari, Marinis, Kornezos, Stamatiou, Nikas, Papadaki, Gkoutzios (CR54) 2012; 4 Yan, Zhou, Cheng, Wang, Yan, Da, Fan, Ji (CR40) 2002; 8 Du, Li, Zhai, Chang, Li (CR28) 2015; 41 Lyshchik (CR12) 2019 Chen, Yang, Yan, Zou, Solbiati, Liu, Dai (CR22) 2004; 232 Gonsalves, Brown (CR37) 2009; 34 Huang, Li, Lu, Luo, Lin, Shi, Li, Liu, Lyshchik (CR11) 2020; 294 Mauri, Porazzi, Cova, Restelli, Tondolo, Bonfanti, Cerri, Ierace, Croce, Solbiati (CR23) 2014; 5 Zhao, Wang, Zhang, Liu, Zhang, Ji, Li, Gan, Zhang, Guo (CR24) 2012; 37 Seyal, Gonzalez-Guindalini, Arslanoglu, Harmath, Lewandowski, Salem, Yaghmai (CR73) 2015; 62 Turtulici, Orlandi, Corazza, Sartoris, Derchi, Silvestri, Baek (CR36) 2014; 40 Yang, Zhang, Xu, Wang, Shen, Zhang, Xu (CR7) 1997; 123 Varela, Real, Burrel, Forner, Sala, Brunet, Ayuso, Castells, Montañá, Llovet, Bruix (CR43) 2007; 46 CR75 Pregler, Beyer, Wiesinger, Nießen, Jung, Stroszczynski, Wiggermann (CR29) 2016; 64 CR74 CR70 Clevert, Paprottka, Helck, Reiser, Trumm (CR35) 2012; 52 Piscaglia, Nolsøe, Dietrich, Cosgrove, Gilja, Bachmann Nielsen, Albrecht, Barozzi, Bertolotto, Catalano, Claudon, Clevert, Correas, D'Onofrio, Drudi, Eyding, Giovannini, Hocke, Ignee, Jung, Klauser, Lassau, Leen, Mathis, Saftoiu, Seidel, Sidhu, ter Haar, Timmerman, Weskott (CR18) 2012; 33 Minami, Kudo, Kawasaki, Kitano, Chung, Maekawa, Shiozaki (CR44) 2003; 180 Lewandowski, Gabr, Abouchaleh, Ali, Al Asadi, Mora, Kulik, Ganger, Desai, Thornburg, Mouli, Hickey, Caicedo, Abecassis, Riaz, Salem (CR69) 2018; 287 Oezdemir, Wessner, Shaw, Eisenbrey, Hoyt (CR55) 2020; 46 Mauri, Gennaro, De Beni, Ierace, Goldberg, Rodari, Solbiati (CR34) 2019; 42 CR2 CR4 CR3 Yan, Zhang, Sun, Cao, Li, Wang, Fan (CR21) 2016; 12 Salvaggio, Campisi, Lo Greco, Cannella, Meloni, Caruso (CR82) 2010; 35 CR5 Forner, Reig, Bruix (CR13) 2018; 391 Bruix, Llovet (CR38) 2002; 35 CR8 CR9 Francica, Meloni, Riccardi, de Sio, Terracciano, Caturelli, Iadevaia, Amoruso, Roselli, Chiang, Scaglione, Pompili (CR25) 2018; 105 Nam, Stanczak, Lyshchik, Machado, Kono, Forsberg, Shaw, Eisenbrey (CR53) 2018; 4 Sala, Llovet, Vilana, Bianchi, Solé, Ayuso, Brú, Bruix (CR15) 2004; 40 Kim, Choi, Lim, Kim, Lee, Kim, Lee, Jeon, Lee, Lee, Lim (CR79) 2005; 56 Kirchner, Marquardt, Werncke, Kirstein, Brunkhorst, Wacker, Vogel, Rodt (CR68) 2019; 44 CR46 Bo, Xu, Sun, Zheng, Guo, Lu, Wu, Xu (CR83) 2014; 7 Zhang, Yu, Li, Wei (CR10) 2017; 8 Xia, Kudo, Minami, Hatanaka, Ueshima, Chung, Hagiwara, Inoue, Ishikawa, Kitai, Takahashi, Tatsumi, Ueda, Hayaishi, Maekawa (CR47) 2008; 75 Shiozawa, Watanabe, Ikehara, Yamamoto, Matsui, Saigusa, Igarashi, Maetani (CR59) 2018; 10 Salem, Lewandowski, Kulik, Wang, Riaz, Ryu, Sato, Gupta, Nikolaidis, Miller, Yaghmai, Ibrahim, Senthilnathan, Baker, Gates, Atassi, Newman, Memon, Chen, Vogelzang, Nemcek, Resnick, Chrisman, Carr, Omary, Abecassis, Benson, Mulcahy (CR66) 2011; 140 CR41 Carr (CR67) 2004; 10 Head, Dodd (CR14) 2004; 127 Brown, Nikolic, Covey, Nutting, Saad, Salem, Sofocleous, Sze (CR39) 2012; 23 Watanabe, Ogawa, Kumagawa, Hirayama, Miura, Matsumoto, Nakagawara, Yamamoto, Moriyama (CR50) 2020; 39 Morimoto, Shirato, Sugimori, Kokawa, Tomita, Saito, Imada, Tanaka, Nozawa, Numata, Tanaka (CR45) 2003; 181 Kim, Kim, Kim, Kim, Ko, Kim, Sung, Ha, Kim, Lee (CR51) 2006; 25 Roccarina, Garcovich, Ainora, Riccardi, Pompili, Gasbarrini, Zocco (CR27) 2015; 7 Ayuso, Rimola, García-Criado (CR16) 2012; 37 Huang, Yusuf, Daneshi, Husainy, Ramnarine, Sellars, Sidhu (CR19) 2017; 37 Lu, Yu, Li, Jiang, Chen, Zhao, Zhou, Wang (CR81) 2007; 33 Meloni, Goldberg, Livraghi, Calliada, Ricci, Rossi, Pallavicini, Campani (CR76) 2001; 177 Shaw, Eisenbrey, Lyshchik, O'Kane, Merton, Machado, Pino, Brown, Forsberg (CR48) 2015; 34 Dill-Macky, Asch, Burns, Wilson (CR80) 2006; 186 Wen, Kudo, Zheng, Minami, Chung, Suetomi, Onda, Kitano, Kawasaki, Maekawa (CR78) 2003; 181 CR17 Paul, Dhamija, Gamanagatti, Sreenivas, Yadav, Jain, Shalimar (CR52) 2017; 98 Lekht, Nayyar, Luu, Guichet, Ho, Ter-Oganesyan, Katz, Gulati (CR58) 2017; 42 Liu, Lin, Lu, Xu, Zheng, Wang, Kuang, Zhuang, Xie (CR49) 2015; 25 Bruix, Sherman (CR61) 2011; 53 Horowitz, Kamel, Arif-Tiwari, Asrani, Hindman, Kaur, McNamara, Noto, Qayyum, Lalani (CR1) 2017; 14 Park, Lee, Rhim, Cha, Kang, Lim, Song, Lim (CR32) 2015; 70 Qu, Yu, Liang, Cheng, Han, Liu, Yu (CR30) 2013; 39 Hickey, Lewandowski, Salem (CR63) 2015; 22 Aslam, Do, Chernyak, Mediratta-Lala (CR72) 2020; 19 Zhang, Yang, Tang (CR6) 2004; 130 Choi, Lim, Lee, Kim, Kim, Lim (CR77) 2003; 22 Moschouris, Malagari, Kalokairinou, Stamatiou, Marinis, Papadaki (CR57) 2011; 13 Wessner, Shaw, Stanczak, Forsberg, Lyshchik, Tan, Eisenbrey (CR60) 2020; 36 Monsky, Keravnou, Averkiou (CR31) 2019; 22 Xu, Lv, Li, Long, Zeng, Su, Zheng (CR33) 2018; 34 Minami, Kudo, Kawasaki, Chung, Ogawa, Shiozaki (CR20) 2004; 183 Imaeda, Yamawaki, Seki, Goto, Iinuma, Kanematsu, Mochizuki, Doi, Saji, Shimokawa (CR42) 1993; 16 Liu, Liu, Xie, Su, Liu, Kuang, Huang, Wang, Zhou, Wang, Lin, Tian (CR56) 2020; 30 Andreana, Isgrò, Marelli, Davies, Yu, Navalkissoor, Burroughs (CR65) 2012; 38 Meloni, Andreano, Zimbaro, Lava, Lazzaroni, Sironi (CR26) 2012; 15 Paul, Sharma (CR64) 2014; 4 Memon, Lewandowski, Kulik, Riaz, Mulcahy, Salem (CR62) 2011; 21 Venkatanarasimha, Gogna, Tong, Damodharan, Chow, Lo, Chandramohan (CR71) 2017; 72 DA Clevert (3059_CR35) 2012; 52 B Yang (3059_CR7) 1997; 123 A Forner (3059_CR13) 2018; 391 C Ayuso (3059_CR16) 2012; 37 EJ Xu (3059_CR33) 2018; 34 K Memon (3059_CR62) 2011; 21 YL Wen (3059_CR78) 2003; 181 XW Bo (3059_CR83) 2014; 7 J Zhang (3059_CR10) 2017; 8 Y Watanabe (3059_CR50) 2020; 39 RJ Lewandowski (3059_CR69) 2018; 287 N Venkatanarasimha (3059_CR71) 2017; 72 FH Yan (3059_CR40) 2002; 8 J Bruix (3059_CR61) 2011; 53 M Liu (3059_CR49) 2015; 25 CK Kim (3059_CR79) 2005; 56 B Pregler (3059_CR29) 2016; 64 SB Paul (3059_CR52) 2017; 98 MD Lu (3059_CR81) 2007; 33 CE Wessner (3059_CR60) 2020; 36 Y Xia (3059_CR47) 2008; 75 SY Yan (3059_CR21) 2016; 12 G Francica (3059_CR25) 2018; 105 BH Zhang (3059_CR6) 2004; 130 3059_CR17 MJ Dill-Macky (3059_CR80) 2006; 186 JM Horowitz (3059_CR1) 2017; 14 HJ Park (3059_CR32) 2015; 70 D Choi (3059_CR77) 2003; 22 D Roccarina (3059_CR27) 2015; 7 P Qu (3059_CR30) 2013; 39 HW Head (3059_CR14) 2004; 127 CF Gonsalves (3059_CR37) 2009; 34 M Morimoto (3059_CR45) 2003; 181 H Moschouris (3059_CR54) 2012; 4 T Kirchner (3059_CR68) 2019; 44 Y Minami (3059_CR44) 2003; 180 K Nam (3059_CR53) 2018; 4 HJ Kim (3059_CR51) 2006; 25 M Varela (3059_CR43) 2007; 46 CM Shaw (3059_CR48) 2015; 34 3059_CR41 G Turtulici (3059_CR36) 2014; 40 BI Carr (3059_CR67) 2004; 10 G Mauri (3059_CR23) 2014; 5 3059_CR46 G Salvaggio (3059_CR82) 2010; 35 X Zhao (3059_CR24) 2012; 37 T Imaeda (3059_CR42) 1993; 16 DB Brown (3059_CR39) 2012; 23 MF Meloni (3059_CR76) 2001; 177 M Sala (3059_CR15) 2004; 40 H Moschouris (3059_CR57) 2011; 13 D Liu (3059_CR56) 2020; 30 A Aslam (3059_CR72) 2020; 19 R Hickey (3059_CR63) 2015; 22 I Oezdemir (3059_CR55) 2020; 46 3059_CR4 3059_CR3 3059_CR2 MF Meloni (3059_CR26) 2012; 15 K Shiozawa (3059_CR59) 2018; 10 3059_CR70 G Mauri (3059_CR34) 2019; 42 R Salem (3059_CR66) 2011; 140 W Monsky (3059_CR31) 2019; 22 3059_CR75 3059_CR74 SB Paul (3059_CR64) 2014; 4 3059_CR9 3059_CR8 AR Seyal (3059_CR73) 2015; 62 A Lyshchik (3059_CR12) 2019 3059_CR5 J Du (3059_CR28) 2015; 41 J Bruix (3059_CR38) 2002; 35 L Andreana (3059_CR65) 2012; 38 MH Chen (3059_CR22) 2004; 232 F Piscaglia (3059_CR18) 2012; 33 DY Huang (3059_CR19) 2017; 37 I Lekht (3059_CR58) 2017; 42 Y Minami (3059_CR20) 2004; 183 JY Huang (3059_CR11) 2020; 294
References_xml	– ident: CR70 – volume: 183 start-page: 153 year: 2004 end-page: 156 ident: CR20 article-title: Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.183.1.1830153 – volume: 46 start-page: 474 year: 2007 end-page: 481 ident: CR43 article-title: Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics publication-title: J Hepatol doi: 10.1016/j.jhep.2006.10.020 – volume: 36 start-page: 218 year: 2020 end-page: 223 ident: CR60 article-title: Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity publication-title: Ultrasound Q doi: 10.1097/RUQ.0000000000000513 – volume: 127 start-page: S167 year: 2004 end-page: S178 ident: CR14 article-title: Thermal ablation for hepatocellular carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.09.031 – volume: 37 start-page: 652 year: 2017 end-page: 664 ident: CR19 article-title: Contrast-enhanced US-guided Interventions: Improving Success Rate and Avoiding Complications Using US Contrast Agents publication-title: Radiographics doi: 10.1148/rg.2017160123 – volume: 98 start-page: 253 year: 2017 end-page: 260 ident: CR52 article-title: Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography publication-title: Diagn Interv Imaging doi: 10.1016/j.diii.2016.09.002 – volume: 44 start-page: 1554 year: 2019 end-page: 1561 ident: CR68 article-title: Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma publication-title: Abdom Radiol (NY) doi: 10.1007/s00261-018-1802-y – volume: 34 start-page: 870 year: 2018 end-page: 876 ident: CR33 article-title: Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging publication-title: Int J Hyperthermia doi: 10.1080/02656736.2017.1373306 – ident: CR74 – ident: CR4 – volume: 33 start-page: 1736 year: 2007 end-page: 1749 ident: CR81 article-title: Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2007.05.004 – volume: 62 start-page: 1111 year: 2015 end-page: 1121 ident: CR73 article-title: Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.27915 – volume: 46 start-page: 2276 year: 2020 end-page: 2286 ident: CR55 article-title: Tumor Vascular Networks Depicted in Contrast-Enhanced Ultrasound Images as a Predictor for Transarterial Chemoembolization Treatment Response publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2020.05.010 – volume: 177 start-page: 375 year: 2001 end-page: 380 ident: CR76 article-title: Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.177.2.1770375 – volume: 7 start-page: 1866 year: 2015 end-page: 1874 ident: CR27 article-title: Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment publication-title: World J Hepatol doi: 10.4254/wjh.v7.i14.1866 – volume: 181 start-page: 57 year: 2003 end-page: 63 ident: CR78 article-title: Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.181.1.1810057 – ident: CR8 – volume: 123 start-page: 357 year: 1997 end-page: 360 ident: CR7 article-title: Prospective study of early detection for primary liver cancer publication-title: J Cancer Res Clin Oncol doi: 10.1007/BF01438313 – volume: 37 start-page: 215 year: 2012 end-page: 230 ident: CR16 article-title: Imaging of HCC publication-title: Abdom Imaging doi: 10.1007/s00261-011-9794-x – volume: 75 start-page: 99 issue: Suppl 1 year: 2008 end-page: 105 ident: CR47 article-title: Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography publication-title: Oncology doi: 10.1159/000173430 – volume: 37 start-page: 885 year: 2012 end-page: 891 ident: CR24 article-title: Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients publication-title: Abdom Imaging doi: 10.1007/s00261-011-9828-4 – volume: 56 start-page: 66 year: 2005 end-page: 73 ident: CR79 article-title: Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2005.03.023 – ident: CR46 – volume: 25 start-page: 2502 year: 2015 end-page: 2511 ident: CR49 article-title: Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST publication-title: Eur Radiol doi: 10.1007/s00330-015-3611-9 – volume: 35 start-page: 447 year: 2010 end-page: 453 ident: CR82 article-title: Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT publication-title: Abdom Imaging doi: 10.1007/s00261-009-9551-6 – volume: 38 start-page: 641 year: 2012 end-page: 649 ident: CR65 article-title: Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: trans-arterial radio-embolisation of HCC publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2011.11.004 – volume: 25 start-page: 477 year: 2006 end-page: 486 ident: CR51 article-title: Assessment of the therapeutic response of hepatocellular carcinoma treated with transcatheter arterial chemoembolization: comparison of contrast-enhanced sonography and 3-phase computed tomography publication-title: J Ultrasound Med doi: 10.7863/jum.2006.25.4.477 – volume: 13 start-page: 296 year: 2011 end-page: 301 ident: CR57 article-title: Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience publication-title: Med Ultrason – ident: CR75 – volume: 130 start-page: 417 year: 2004 end-page: 422 ident: CR6 article-title: Randomized controlled trial of screening for hepatocellular carcinoma publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-004-0552-0 – volume: 70 start-page: 387 year: 2015 end-page: 394 ident: CR32 article-title: Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography publication-title: Clin Radiol doi: 10.1016/j.crad.2014.12.003 – volume: 12 start-page: 1345 year: 2016 end-page: 1348 ident: CR21 article-title: Comparison of real-time contrast-enhanced ultrasonography and standard ultrasonography in liver cancer microwave ablation publication-title: Exp Ther Med doi: 10.3892/etm.2016.3448 – volume: 4 start-page: S112 year: 2014 end-page: S121 ident: CR64 article-title: Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma publication-title: J Clin Exp Hepatol doi: 10.1016/j.jceh.2014.03.048 – volume: 22 start-page: 706 year: 2015 end-page: 707 ident: CR63 article-title: Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4165-9 – ident: CR9 – volume: 181 start-page: 65 year: 2003 end-page: 69 ident: CR45 article-title: Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.181.1.1810065 – volume: 53 start-page: 1020 year: 2011 end-page: 1022 ident: CR61 article-title: Management of hepatocellular carcinoma: an update publication-title: Hepatology doi: 10.1002/hep.24199 – ident: CR5 – volume: 72 start-page: 1002 year: 2017 end-page: 1013 ident: CR71 article-title: Radioembolisation of hepatocellular carcinoma: a primer publication-title: Clin Radiol doi: 10.1016/j.crad.2017.07.021 – volume: 41 start-page: 2400 year: 2015 end-page: 2411 ident: CR28 article-title: Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2015.05.004 – volume: 19 start-page: 437 year: 2020 end-page: 447 ident: CR72 article-title: LI-RADS imaging criteria for HCC diagnosis and treatment: emerging evidence publication-title: Curr Hepatlogy doi: 10.1007/s11901-020-00546-6 – volume: 22 start-page: 323 year: 2019 end-page: 335 ident: CR31 article-title: Contrast-enhanced ultrasound to ultrasound fusion during microwave ablation: feasibility study in a perfused porcine liver model publication-title: J Ultrasound doi: 10.1007/s40477-019-00366-5 – volume: 34 start-page: 859 year: 2015 end-page: 867 ident: CR48 article-title: Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study publication-title: J Ultrasound Med doi: 10.7863/ultra.34.5.859 – volume: 39 start-page: 431 year: 2020 end-page: 440 ident: CR50 article-title: Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization publication-title: J Ultrasound Med doi: 10.1002/jum.15118 – volume: 40 start-page: 1352 year: 2004 end-page: 1360 ident: CR15 article-title: Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.20465 – volume: 4 start-page: 035039 year: 2018 ident: CR53 article-title: Evaluation of Hepatocellular Carcinoma Transarterial Chemoembolization using Quantitative Analysis of 2D and 3D Real-time Contrast Enhanced Ultrasound publication-title: Biomed Phys Eng Express doi: 10.1088/2057-1976/aabb14 – volume: 4 start-page: 379 year: 2012 end-page: 386 ident: CR54 article-title: Hepatocellular carcinoma treated with transarterial chemoembolization: Evaluation with parametric contrast-enhanced ultrasonography publication-title: World J Radiol doi: 10.4329/wjr.v4.i8.379 – volume: 391 start-page: 1301 year: 2018 end-page: 1314 ident: CR13 article-title: Hepatocellular carcinoma publication-title: Lancet doi: 10.1016/S0140-6736(18)30010-2 – ident: CR2 – volume: 33 start-page: 33 year: 2012 end-page: 59 ident: CR18 article-title: The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications publication-title: Ultraschall Med doi: 10.1055/s-0031-1281676 – volume: 35 start-page: 519 year: 2002 end-page: 524 ident: CR38 article-title: Prognostic prediction and treatment strategy in hepatocellular carcinoma publication-title: Hepatology doi: 10.1053/jhep.2002.32089 – year: 2019 ident: CR12 publication-title: Specialty Imaging: Fundamentals of CEUS – volume: 15 start-page: 207 year: 2012 end-page: 214 ident: CR26 article-title: Contrast enhanced ultrasound: Roles in immediate post-procedural and 24-h evaluation of the effectiveness of thermal ablation of liver tumors publication-title: J Ultrasound doi: 10.1016/j.jus.2012.09.001 – volume: 42 start-page: 60 year: 2019 end-page: 68 ident: CR34 article-title: Real-Time US-(18)FDG-PET/CT Image Fusion for Guidance of Thermal Ablation of (18)FDG-PET-Positive Liver Metastases: The Added Value of Contrast Enhancement publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-018-2082-1 – volume: 16 start-page: 209 year: 1993 end-page: 213 ident: CR42 article-title: Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology publication-title: Cardiovasc Intervent Radiol doi: 10.1007/BF02602962 – volume: 294 start-page: 329 year: 2020 end-page: 339 ident: CR11 article-title: Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma publication-title: Radiology doi: 10.1148/radiol.2019191086 – volume: 23 start-page: 287 year: 2012 end-page: 294 ident: CR39 article-title: Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2011.11.029 – volume: 140 start-page: 497 year: 2011 end-page: 507.e2 ident: CR66 article-title: Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2010.10.049 – volume: 232 start-page: 260 year: 2004 end-page: 271 ident: CR22 article-title: Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients–mathematic model, overlapping mode, and electrode placement process publication-title: Radiology doi: 10.1148/radiol.2321030821 – volume: 39 start-page: 1571 year: 2013 end-page: 1579 ident: CR30 article-title: Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2013.03.030 – volume: 14 start-page: S391 year: 2017 end-page: s405 ident: CR1 article-title: ACR Appropriateness Criteria(®) Chronic Liver Disease publication-title: J Am Coll Radiol doi: 10.1016/j.jacr.2017.08.045 – volume: 10 start-page: 95 year: 2018 end-page: 104 ident: CR59 article-title: Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma publication-title: World J Hepatol doi: 10.4254/wjh.v10.i1.95 – volume: 64 start-page: 483 year: 2016 end-page: 490 ident: CR29 article-title: Microwave ablation of large HCC lesions: Added value of CEUS examinations for ablation success control publication-title: Clin Hemorheol Microcirc doi: 10.3233/CH-168113 – volume: 7 start-page: 6108 year: 2014 end-page: 6116 ident: CR83 article-title: Bipolar radiofrequency ablation for liver tumors: comparison of contrast-enhanced ultrasound with contrast-enhanced MRI/CT in the posttreatment imaging evaluation publication-title: Int J Clin Exp Pathol – volume: 34 start-page: 557 year: 2009 end-page: 565 ident: CR37 article-title: Chemoembolization of hepatic malignancy publication-title: Abdom Imaging doi: 10.1007/s00261-008-9446-y – volume: 40 start-page: 1447 year: 2014 end-page: 1452 ident: CR36 article-title: Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2014.02.017 – volume: 52 start-page: 205 year: 2012 end-page: 216 ident: CR35 article-title: Image fusion in the management of thermal tumor ablation of the liver publication-title: Clin Hemorheol Microcirc doi: 10.3233/CH-2012-1598 – volume: 10 start-page: S107 year: 2004 end-page: S110 ident: CR67 article-title: Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients publication-title: Liver Transpl doi: 10.1002/lt.20036 – ident: CR3 – ident: CR17 – volume: 5 start-page: 209 year: 2014 end-page: 216 ident: CR23 article-title: Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment publication-title: Insights Imaging doi: 10.1007/s13244-014-0315-7 – volume: 30 start-page: 2365 year: 2020 end-page: 2376 ident: CR56 article-title: Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound publication-title: Eur Radiol doi: 10.1007/s00330-019-06553-6 – volume: 287 start-page: 1050 year: 2018 end-page: 1058 ident: CR69 article-title: Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma publication-title: Radiology doi: 10.1148/radiol.2018171768 – volume: 186 start-page: S287 year: 2006 end-page: S295 ident: CR80 article-title: Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.04.1916 – volume: 42 start-page: 1400 year: 2017 end-page: 1407 ident: CR58 article-title: Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series publication-title: Abdom Radiol (NY) doi: 10.1007/s00261-016-1016-0 – volume: 8 start-page: 75418 year: 2017 end-page: 75426 ident: CR10 article-title: Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016 publication-title: Oncotarget doi: 10.18632/oncotarget.20049 – volume: 22 start-page: 1163 year: 2003 end-page: 1172 ident: CR77 article-title: Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent publication-title: J Ultrasound Med doi: 10.7863/jum.2003.22.11.1163 – ident: CR41 – volume: 105 start-page: 96 year: 2018 end-page: 101 ident: CR25 article-title: Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers publication-title: A multicenter study. Eur J Radiol doi: 10.1016/j.ejrad.2018.05.030 – volume: 180 start-page: 703 year: 2003 end-page: 708 ident: CR44 article-title: Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.180.3.1800703 – volume: 21 start-page: 294 year: 2011 end-page: 302 ident: CR62 article-title: Radioembolization for primary and metastatic liver cancer publication-title: Semin Radiat Oncol doi: 10.1016/j.semradonc.2011.05.004 – volume: 8 start-page: 658 year: 2002 end-page: 662 ident: CR40 article-title: Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE publication-title: World J Gastroenterol doi: 10.3748/wjg.v8.i4.658 – volume: 105 start-page: 96 year: 2018 ident: 3059_CR25 publication-title: A multicenter study. Eur J Radiol doi: 10.1016/j.ejrad.2018.05.030 – volume: 10 start-page: 95 year: 2018 ident: 3059_CR59 publication-title: World J Hepatol doi: 10.4254/wjh.v10.i1.95 – volume: 41 start-page: 2400 year: 2015 ident: 3059_CR28 publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2015.05.004 – volume: 287 start-page: 1050 year: 2018 ident: 3059_CR69 publication-title: Radiology doi: 10.1148/radiol.2018171768 – volume: 34 start-page: 557 year: 2009 ident: 3059_CR37 publication-title: Abdom Imaging doi: 10.1007/s00261-008-9446-y – volume: 140 start-page: 497 year: 2011 ident: 3059_CR66 publication-title: Gastroenterology doi: 10.1053/j.gastro.2010.10.049 – ident: 3059_CR3 – ident: 3059_CR74 doi: 10.1148/radiol.2020202321 – volume: 30 start-page: 2365 year: 2020 ident: 3059_CR56 publication-title: Eur Radiol doi: 10.1007/s00330-019-06553-6 – volume: 36 start-page: 218 year: 2020 ident: 3059_CR60 publication-title: Ultrasound Q doi: 10.1097/RUQ.0000000000000513 – volume: 8 start-page: 75418 year: 2017 ident: 3059_CR10 publication-title: Oncotarget doi: 10.18632/oncotarget.20049 – volume: 5 start-page: 209 year: 2014 ident: 3059_CR23 publication-title: Insights Imaging doi: 10.1007/s13244-014-0315-7 – volume: 4 start-page: S112 year: 2014 ident: 3059_CR64 publication-title: J Clin Exp Hepatol doi: 10.1016/j.jceh.2014.03.048 – volume: 64 start-page: 483 year: 2016 ident: 3059_CR29 publication-title: Clin Hemorheol Microcirc doi: 10.3233/CH-168113 – volume: 8 start-page: 658 year: 2002 ident: 3059_CR40 publication-title: World J Gastroenterol doi: 10.3748/wjg.v8.i4.658 – volume: 35 start-page: 519 year: 2002 ident: 3059_CR38 publication-title: Hepatology doi: 10.1053/jhep.2002.32089 – volume: 98 start-page: 253 year: 2017 ident: 3059_CR52 publication-title: Diagn Interv Imaging doi: 10.1016/j.diii.2016.09.002 – volume: 14 start-page: S391 year: 2017 ident: 3059_CR1 publication-title: J Am Coll Radiol doi: 10.1016/j.jacr.2017.08.045 – volume: 391 start-page: 1301 year: 2018 ident: 3059_CR13 publication-title: Lancet doi: 10.1016/S0140-6736(18)30010-2 – volume: 40 start-page: 1352 year: 2004 ident: 3059_CR15 publication-title: Hepatology doi: 10.1002/hep.20465 – volume: 181 start-page: 57 year: 2003 ident: 3059_CR78 publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.181.1.1810057 – volume: 33 start-page: 33 year: 2012 ident: 3059_CR18 publication-title: Ultraschall Med doi: 10.1055/s-0031-1281676 – volume: 34 start-page: 859 year: 2015 ident: 3059_CR48 publication-title: J Ultrasound Med doi: 10.7863/ultra.34.5.859 – volume: 40 start-page: 1447 year: 2014 ident: 3059_CR36 publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2014.02.017 – ident: 3059_CR2 – volume: 181 start-page: 65 year: 2003 ident: 3059_CR45 publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.181.1.1810065 – ident: 3059_CR41 – volume: 183 start-page: 153 year: 2004 ident: 3059_CR20 publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.183.1.1830153 – volume: 22 start-page: 1163 year: 2003 ident: 3059_CR77 publication-title: J Ultrasound Med doi: 10.7863/jum.2003.22.11.1163 – volume: 46 start-page: 2276 year: 2020 ident: 3059_CR55 publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2020.05.010 – volume: 21 start-page: 294 year: 2011 ident: 3059_CR62 publication-title: Semin Radiat Oncol doi: 10.1016/j.semradonc.2011.05.004 – volume: 4 start-page: 035039 year: 2018 ident: 3059_CR53 publication-title: Biomed Phys Eng Express doi: 10.1088/2057-1976/aabb14 – volume: 39 start-page: 1571 year: 2013 ident: 3059_CR30 publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2013.03.030 – volume: 38 start-page: 641 year: 2012 ident: 3059_CR65 publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2011.11.004 – volume: 42 start-page: 60 year: 2019 ident: 3059_CR34 publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-018-2082-1 – volume: 25 start-page: 477 year: 2006 ident: 3059_CR51 publication-title: J Ultrasound Med doi: 10.7863/jum.2006.25.4.477 – volume: 37 start-page: 652 year: 2017 ident: 3059_CR19 publication-title: Radiographics doi: 10.1148/rg.2017160123 – volume: 12 start-page: 1345 year: 2016 ident: 3059_CR21 publication-title: Exp Ther Med doi: 10.3892/etm.2016.3448 – volume: 13 start-page: 296 year: 2011 ident: 3059_CR57 publication-title: Med Ultrason – volume: 23 start-page: 287 year: 2012 ident: 3059_CR39 publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2011.11.029 – volume: 19 start-page: 437 year: 2020 ident: 3059_CR72 publication-title: Curr Hepatlogy doi: 10.1007/s11901-020-00546-6 – volume: 39 start-page: 431 year: 2020 ident: 3059_CR50 publication-title: J Ultrasound Med doi: 10.1002/jum.15118 – volume: 22 start-page: 323 year: 2019 ident: 3059_CR31 publication-title: J Ultrasound doi: 10.1007/s40477-019-00366-5 – volume: 177 start-page: 375 year: 2001 ident: 3059_CR76 publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.177.2.1770375 – volume: 4 start-page: 379 year: 2012 ident: 3059_CR54 publication-title: World J Radiol doi: 10.4329/wjr.v4.i8.379 – ident: 3059_CR75 doi: 10.1109/ULTSYM.2019.8926264 – volume: 37 start-page: 885 year: 2012 ident: 3059_CR24 publication-title: Abdom Imaging doi: 10.1007/s00261-011-9828-4 – ident: 3059_CR5 – volume: 16 start-page: 209 year: 1993 ident: 3059_CR42 publication-title: Cardiovasc Intervent Radiol doi: 10.1007/BF02602962 – ident: 3059_CR9 – volume: 294 start-page: 329 year: 2020 ident: 3059_CR11 publication-title: Radiology doi: 10.1148/radiol.2019191086 – volume: 22 start-page: 706 year: 2015 ident: 3059_CR63 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4165-9 – volume: 130 start-page: 417 year: 2004 ident: 3059_CR6 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-004-0552-0 – volume: 123 start-page: 357 year: 1997 ident: 3059_CR7 publication-title: J Cancer Res Clin Oncol doi: 10.1007/BF01438313 – volume: 127 start-page: S167 year: 2004 ident: 3059_CR14 publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.09.031 – volume-title: Specialty Imaging: Fundamentals of CEUS year: 2019 ident: 3059_CR12 – ident: 3059_CR46 doi: 10.1016/j.jvir.2006.10.016 – volume: 25 start-page: 2502 year: 2015 ident: 3059_CR49 publication-title: Eur Radiol doi: 10.1007/s00330-015-3611-9 – volume: 53 start-page: 1020 year: 2011 ident: 3059_CR61 publication-title: Hepatology doi: 10.1002/hep.24199 – volume: 10 start-page: S107 year: 2004 ident: 3059_CR67 publication-title: Liver Transpl doi: 10.1002/lt.20036 – volume: 7 start-page: 1866 year: 2015 ident: 3059_CR27 publication-title: World J Hepatol doi: 10.4254/wjh.v7.i14.1866 – volume: 37 start-page: 215 year: 2012 ident: 3059_CR16 publication-title: Abdom Imaging doi: 10.1007/s00261-011-9794-x – volume: 232 start-page: 260 year: 2004 ident: 3059_CR22 publication-title: Radiology doi: 10.1148/radiol.2321030821 – volume: 46 start-page: 474 year: 2007 ident: 3059_CR43 publication-title: J Hepatol doi: 10.1016/j.jhep.2006.10.020 – volume: 62 start-page: 1111 year: 2015 ident: 3059_CR73 publication-title: Hepatology doi: 10.1002/hep.27915 – volume: 186 start-page: S287 year: 2006 ident: 3059_CR80 publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.04.1916 – volume: 33 start-page: 1736 year: 2007 ident: 3059_CR81 publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2007.05.004 – volume: 44 start-page: 1554 year: 2019 ident: 3059_CR68 publication-title: Abdom Radiol (NY) doi: 10.1007/s00261-018-1802-y – ident: 3059_CR4 – ident: 3059_CR70 doi: 10.1007/s00270-020-02712-1 – ident: 3059_CR8 – volume: 34 start-page: 870 year: 2018 ident: 3059_CR33 publication-title: Int J Hyperthermia doi: 10.1080/02656736.2017.1373306 – volume: 75 start-page: 99 issue: Suppl 1 year: 2008 ident: 3059_CR47 publication-title: Oncology doi: 10.1159/000173430 – ident: 3059_CR17 doi: 10.1102/1470-7330.2011.9042 – volume: 180 start-page: 703 year: 2003 ident: 3059_CR44 publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.180.3.1800703 – volume: 42 start-page: 1400 year: 2017 ident: 3059_CR58 publication-title: Abdom Radiol (NY) doi: 10.1007/s00261-016-1016-0 – volume: 35 start-page: 447 year: 2010 ident: 3059_CR82 publication-title: Abdom Imaging doi: 10.1007/s00261-009-9551-6 – volume: 7 start-page: 6108 year: 2014 ident: 3059_CR83 publication-title: Int J Clin Exp Pathol – volume: 15 start-page: 207 year: 2012 ident: 3059_CR26 publication-title: J Ultrasound doi: 10.1016/j.jus.2012.09.001 – volume: 52 start-page: 205 year: 2012 ident: 3059_CR35 publication-title: Clin Hemorheol Microcirc doi: 10.3233/CH-2012-1598 – volume: 72 start-page: 1002 year: 2017 ident: 3059_CR71 publication-title: Clin Radiol doi: 10.1016/j.crad.2017.07.021 – volume: 70 start-page: 387 year: 2015 ident: 3059_CR32 publication-title: Clin Radiol doi: 10.1016/j.crad.2014.12.003 – volume: 56 start-page: 66 year: 2005 ident: 3059_CR79 publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2005.03.023
SSID	ssj0001651125 ssj0008379
Score	2.4718328
SecondaryResourceType	review_article
Snippet	Hepatocellular carcinoma (HCC) is a global problem constituting the second leading cause of cancer deaths worldwide, thereby necessitating an accurate and...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	3579
SubjectTerms	Cancer Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - therapy Computed tomography Contrast Media Gastroenterology Hepatocellular carcinoma Hepatology Humans Imaging Liver Liver cancer Liver Neoplasms - diagnostic imaging Liver Neoplasms - therapy Magnetic Resonance Imaging Medical diagnosis Medicine Medicine & Public Health Neoplasm Recurrence, Local Radiology Special Section: HCC Treatment Temporal resolution Tumors Ultrasonic imaging Ultrasonography Ultrasound
SummonAdditionalLinks	– databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9tAEB0VkCouqNBCDRQtUg9U7Qp77djOqaoiUFQJLhApN2s_RSSwaeIc-PfMrDdGKYKLFXk3cdZv7H2zM_sG4HtiUuWQWXChs4Jneqi5LFM8aJUkMhVGa6_2eZ2PJ9nf6WAaFtwWIa1y9U70L2rTaFojPxckFTbAyTT__fiPU9Uoiq6GEhobsEXSZZTSVUx7hwvZhdfaE2mOXnOcTcOmGb91zjsfnBIUyOSH_Gl9YnrFNl8nTf4XOfUT0uUn2AlMkv3poN-FD7beg49XIVb-GRoSnprLRcttfefj_Gx5TyeokBI7G11Mbn6wWc3GoxEzXcLdbMEktslerZM1jrXLh2bO5l0urWVtw3D-a6igA5F41m3gQn_7C0wuL25HYx7KK3CEJWt5qkSRSIf31cZpZoWJjRJKxcIViRnYvDRiiJ9pS5WSQ1U66dDZ02XhVG6JBuzDZt3U9iswnSHAskQ2QGtKJsdfzSjeGCPaunQugmR1bysdtMepBMZ91asmezwqxKPyeFRPEfzsv_PYKW-82_t4BVkVnsJF9WIzEZz2zfj8UFBE1rZZUh8qeoO8OYngoEO4vxy67-gdiiKCYg37vgNpc6-31LM7r9FdDnKSvYng18pKXv7W26M4fH8UR7AtvMVS_uExbLbzpf2GnKhVJ97wnwFNgglx priority: 102 providerName: ProQuest
Title	Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies
URI	https://link.springer.com/article/10.1007/s00261-021-03059-y https://www.ncbi.nlm.nih.gov/pubmed/33825927 https://www.proquest.com/docview/2552759376 https://www.proquest.com/docview/2509610801 https://pubmed.ncbi.nlm.nih.gov/PMC8569604
Volume	46
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwEB6xXQlx4f0ILJWROIAgq8RxXsdt1W4FokJApXKKbMfRViwJapPD8uuZcR7QXUDaS1rVblo7n-NvMjPfALz080AVyCxcrkXsCp1qVyYBHrTyfRnwXGur9rmMFivxbh2uu6SwXR_t3rsk7Z16SHaz5oJLIQUE0tS9OIBD5B-eGMHhyenX9388W4mIRoS2rlyEBrMn1l2-zN9PtL8nXSGaV-MlLzlN7V40vwOrfhRtCMq346ZWx_rnJYHH6w7zLtzuyCk7adF0D26Y8j7c_NC53x9ARVpWW7mrXVOe2dAB1pzTB1Sbib2azlafX7NNyRbTKcvbGL7Njklsk4MAKKsKVjffqy3btuG5htUVwy21ohoRZBewNicMTfiHsJrPvkwXblexwcUrLWo3UDz2ZRGG3HiBMDz3csWV8ngR-3looiTnKb6nLC0lU5UUskD7USdxoSJDzOIRjMqqNE-AaYGYkQkSDHpMlUd4VkEuTA8BpJOicMDvr1mmOzlzqqpxng1CzHYmM5zJzM5kduHAm-E7P1oxj__2PuqhkHULe5dxUqwLkdNFDrwYmnFJkp9FlqZqqA_V0UEq7jvwuEXO8HNBgCZ5ymMH4j1MDR1I7nu_pdycWdnvJIxISceBtz1wfv-tf4_i6fW6P4Nb3GKPQhyPYFRvG_McaVetxnAQr2M8JvPTMa64-WSyHHcrD18ns-XHT78A6A8pWg
linkProvider	Springer Nature
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgEXVF7FUGCRQALBqvbasdeHCqHQkNLHhUbKzeyu12qkYpfEEcqf4jcys35UoaK3XiIru14_ZmZnxjPzDcCbIA91gZYFFyZKeGRSw5UM8cfoIFChyI1xaJ8n8XgSfZsOphvwp6uFobTKbk90G3VeGfpGvisIKmyAyjT-dPGLU9coiq52LTQatji0q9_osi32Dr4gfd8KMdo_HY5521WA491ENQ-1SAJV4HLWDyMrcj_XQmtfFEmQD2wsc5HiMVUSaZVqWagCfRwjk0LHlrQfrnsLbuN4ShIlR1_7nV822H4ijNFL96NpW6TjSvWcs8MpIYJELOWrdUV4xbq9mqT5T6TWKcDRFtxvLVf2uWG1B7Bhy4dw57iNzT-CioCu5mpRc1ueubwCtjynP6hxE3s33J98f89mJRsPhyxvEvxmC6ZwTPXooKwqWL38Wc3ZvMndtayuGOrbihpIkNPAmoIx9O8fw-RGXvwT2Cyr0j4FZiJkKCXR-qBvWHmMq0YU3_SRu4wsCg-C7t1mpsU6p5Yb51mP0uzokSE9MkePbOXBh_6ciwbp49rZOx3JslbqF9klj3rwuh9GeaUgjCpttaQ51GQH7fTAg-2Gwv3lwhD99VQkHiRrtO8nEBb4-kg5O3OY4HIQE8yOBx87Lrm8rf8_xbPrn-IV3B2fHh9lRwcnh8_hnnDcS7mPO7BZz5f2BdpjtX7phIDBj5uWur_BqkZf
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB9qheKL-G206goKii5NNt8PInLtcbVaBD24t3R3s0sPalLvcsj9a_51zmw-ylnsW1-OcLvZfMzMzkxm5jcAr4IyVBYtCy50lPJI55rLLMQfrYJAhqLU2qF9HieTafR5Fs-24E9fC0Nplf2e6Dbqstb0jXxPEFRYjMo02bNdWsS3_fHH81-cOkhRpLVvp9GyyJFZ_0b3bfnhcB9p_VqI8cGP0YR3HQY43lnU8FCJNJAWlzZ-GBlR-qUSSvnCpkEZmyQrRY7HVFWkZK4yKy36OzpLrUoMaUJc9wbcTMM4IBlLZ4Ozh5aNw_kTYYIeux_NuoIdV7bnHB9OyREkbjlfbyrFS5bu5YTNf6K2ThmO78Dtzopln1q2uwtbproHO1-7OP19qAn0aiGXDTfVqcsxYKsz-oOaOLE3o4Pp97dsXrHJaMTKNtlvvmQSx-SAFMpqy5rVz3rBFm0er2FNzVD31tRMghwI1haPoa__AKbX8uIfwnZVV-YxMB0hc8kMLRH6nlUmuGpEsU4fOU1n1noQ9O-20B3uObXfOCsGxGZHjwLpUTh6FGsP3g3nnLeoH1fO3u1JVnQ7wLK44FcPXg7DKLsUkJGVqVc0hxruoM0eePCopfBwuTBE3z0XqQfpBu2HCYQLvjlSzU8dPngWJwS548H7nksubuv_T_Hk6qd4ATsob8WXw-Ojp3BLOOalNMhd2G4WK_MMTbNGPXcywODkuoXuL-BmSow
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Contrast-enhanced+ultrasound+%28CEUS%29+in+HCC+diagnosis+and+assessment+of+tumor+response+to+locoregional+therapies&rft.jtitle=Abdominal+radiology+%28New+York%29&rft.au=Eisenbrey%2C+John+R.&rft.au=Gabriel%2C+Helena&rft.au=Savsani%2C+Esika&rft.au=Lyshchik%2C+Andrej&rft.date=2021-08-01&rft.pub=Springer+US&rft.issn=2366-004X&rft.eissn=2366-0058&rft.volume=46&rft.issue=8&rft.spage=3579&rft.epage=3595&rft_id=info:doi/10.1007%2Fs00261-021-03059-y&rft.externalDocID=10_1007_s00261_021_03059_y
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2366-004X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2366-004X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2366-004X&client=summon